MAPS PrEP Van Study

Duke University

Status and phase: Enrolling; Phase 4

Conditions: HIV Infection

Treatments: Drug: Pre-Exposure Prophylaxis (PrEP)

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT06908252

5P30AI064518-20 (U.S. NIH Grant/Contract)

Pro00116108

Details and patient eligibility

About

For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.

Full description

The purpose of this study is to evaluate a pilot program that provides Pre-Exposure Prophylaxis (PrEP) for people who use drugs (PWUD) and are at risk for contracting HIV. Given the ongoing overdose crisis and the risk of HIV among PWUD, this study aims to assess weather offering oral PrEP on a Medical Mobile Unit (MMU) is a viable strategy for preventing HIV transmission in high-risk populations. The other goal of this study is to assess community perceptions of PrEP and perceived HIV risk among Syringe Service Program (SSP) clients visiting a MMU.

Enrollment: 20 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• 18 years or older, active drug injection user and/or sexually active, referred from the Syringe Service Program

Exclusion criteria

• positive HIV status

Trial design

Primary purpose: Prevention

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

20 participants in 1 patient group

PrEP

Experimental group

Description:

All eligible participants will be given oral PrEP pills to reduce their risk for contracting HIV.

Treatment:

Drug: Pre-Exposure Prophylaxis (PrEP)